Composition comprising cell and biocompatible polymer

a biocompatible polymer and cell technology, applied in the direction of genetically modified cells, skeletal/connective tissue cells, peptide/protein ingredients, etc., can solve the problems of difficult treatment, long time to obtain, and poor regenerative power of central nervous system tissues, so as to improve the survival rate of cells and suppress the outflow of cells

Inactive Publication Date: 2012-10-18
FUJIFILM CORP +1
View PDF2 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0007]It is an object of the present invention to provide a cell-containing composition capable of...

Problems solved by technology

It is known that the central nervous system tissues have an extremely poor regenerative power.
Thus, if these tissues are once injured, it is basically difficult to treat them.
However, it takes a long period of time to obtain the effects of ...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition comprising cell and biocompatible polymer
  • Composition comprising cell and biocompatible polymer
  • Composition comprising cell and biocompatible polymer

Examples

Experimental program
Comparison scheme
Effect test

example 1

Preparation of Biocompatible Polymer Particles

[0128]A 18 ml of 3% Glutaraldehyde solution was added into 162 ml of 10% (w / v) CBE3 aqueous solution. The mixture was left at 4 oC for 18 h to make a hydro gel. The hydro gel was freeze dried and milled to make small pieces of CBE3 particles. The photographs of the obtained CBE3 particles are shown in FIG. 1.

example 2

In Vitro Cell Viability on Rat Hippocampal Slice

[0129]10% (v / v) of CBE3 particles or animal gelatin particles were suspended in a medium (α-MEM; 10% FBS; 1% PS). Thereafter, GFP-labeled Notch intracellular gene induced bone marrow derived cells (SB623 manufactured by Sanbio) were suspended in each solution. The thus produced cell suspension was added onto the hippocampal section of a P9 rat placed on a 12-well plastic plate.

[0130]The section was then incubated in a CO2 incubator at 37° C. One, two, five, nine and fourteen days after initiation of the incubation, cells expressing GFP on the section were observed under a fluorescent microscope, and the number of such cells was counted. The cells that expressed GFP were considered to be surviving cells. Thus, the survival rate of the cells was evaluated as a ratio with respect to the number of cells 1 day after initiation of the inoculation. The results are shown in FIG. 2.

[0131]The survival rate of the cells was improved by the effect...

example 3

In Vitro Cell Viability in Ultra Low Attachment Culture Plate

[0132]0.01 cm3 / well of CBE3 and animal gelatin particles in 500 ul of α-MEM are placed in a Ultra Low Attachment Culture Dish (manufactured by Corning). Thereafter, 50,000 of Notch intracellular gene induced bone marrow derived cells (SB623 manufactured by Sanbio) were plated and incubated in a CO2 incubator at 37° C. 2 hours and one, four, and seven days after initiation of the incubation, samples are filtered by a cell strainer (mesh size 40 um) and DNA is extracted from recovered samples by dissolving in papain solution (2.5 mU / ml papain, 5 mM L-cystein, 5 mM EDTA) at 60 oC overnight. By using standard curve, number of cells on particles was counted. Because live cells adhere on particles and dead cells do not, the survival rate of the cells was evaluated as a ratio with respect to the number of cells 0 day (2 hours) after plating.

[0133]As shown in FIG. 3, the survival rate of the cells was improved by CBE3 particles or...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Fractionaaaaaaaaaa
Adhesion strengthaaaaaaaaaa
Molecular weightaaaaaaaaaa
Login to view more

Abstract

It is an object of the present invention to provide a cell-containing composition capable of suppressing the outflow of the cells after transplantation and improving the survival rate of the cells. The present invention provides a composition which comprises any of bone marrow stromal cell-derived neural precursor cells, bone marrow stromal cell-derived Schwann cells, or bone marrow stromal cell-derived skeletal muscle cells; and a biocompatible polymer.

Description

TECHNICAL FIELD[0001]The present invention relates to a composition which comprises any of bone marrow stromal cell-derived neural precursor cells, bone marrow stromal cell-derived Schwann cells, or bone marrow stromal cell-derived skeletal muscle cells; and a biocompatible polymer.BACKGROUND ART[0002]The injury of central nervous system tissues causes various types of diseases. For example, cerebral infarction is caused by the necrosis of brain tissues due to ischemia. Parkinson's disease is a neurodegenerative disease caused by degeneration of dopamine-producing cells existing in the substantia nigra in the midbrain. Spinal cord injury is mainly caused by damaging the spinal cord by strong external force.[0003]The disorders of motor function, sensory function and cognitive function are generated as a result of the loss of central nervous system tissues. It is known that the central nervous system tissues have an extremely poor regenerative power. Thus, if these tissues are once in...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K35/28A61K35/34A61K35/30A61P21/00A61P25/00
CPCC12N5/0622C12N2501/01C12N2501/115C12N2501/13C12N2533/54C12N2501/385C12N2501/42C12N2506/1353C12N2510/00C12N2501/135A61K38/39A61P21/00A61P25/00A61P25/16A61P9/10A61K35/30C12N5/0623
Inventor MIYOSHI, HAYATOOKAMURA, AITATE, CIARA C.DAO, MONIQUE A.
Owner FUJIFILM CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products